{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "FDA Proposes Sweeping Changes to Accelerate Biosimilar Development",
    "url": "https://www.lexblog.com/2025/11/07/fda-proposes-sweeping-changes-to-accelerate-biosimilar-development/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-RG5MHCH4",
        "url": "https://www.lexblog.com/lib/RG5MHCH4/"
    },
    "datePublished": "2025-11-07T11:39:43-05:00",
    "dateModified": "2025-11-07T08:40:49-05:00",
    "author": {
        "@type": "Person",
        "name": "Michael Ellenberger, Aydin H. Harston"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Rothwell Figg"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Biosimilars Law Bulletin",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.biosimilarsip.com/?p=5818",
    "sourceStability": "may-move"
}